In addition, we found that miR-5193 (human miR-5110 homolog) was enriched in TT-EVs from lung cancer patients, and TT-EVs significantly inhibited CD93 expression in NCI-H2452 cells (Figure 5C-D). Here, CD93 is linked to lung carcinoma.